Cuantificación de la respuesta al placebo en la colitis ulcerosa

Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 1999
Cargando información sobre las referencias

CRD COMMENTARY:

The review systematically searched for relevant trials, and clearly described the inclusion criteria. Studies reported as abstracts or non-English language articles were excluded. The details of the individual studies were not presented. The results of active treatments were unavailable and, therefore, it is difficult to estimate the clinical importance of a placebo remission rate of 10% and a placebo benefit rate of 30%.
Epistemonikos ID: 8a1fac98a2bc6e4f49b3008651030c246cd98e9d
First added on: Feb 05, 2012